Auf dieser Seite
CDNA CareDx, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 30, 2026
$67,15
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$13,9552-Wochen-Tief
$69,8052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$3.46B
P/E (TTM)
32.4
EPS (TTM)
$2.07
Umsatz (TTM)
$458M
Ihre Abzeichen
52W-Spanne
$14–$70
Analystenbewertung
STRONG BUY
Kursziel
$59
P/E
32.4
ROE
29.5%
Nettogewinnmarge
24.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
CDNA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$67.15
Marktkapitalisierung (MRQ)
$3.46B
P/E (TTM)
32.4
EPS (TTM)
$2.07
Umsatz (TTM)
$458M
ROE (TTM)
29.5%
52W-Spanne
$14–$70
CDNA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über CareDx, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter761
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$380M2017-12-31 → 2025-12-31
EPS$-0.402017-12-31 → 2025-12-31
Freier Cashflow·2017-12-31 → 2018-12-31
Nettogewinnmarge24.2%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CDNA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 32.45-Jahres-Durchschnitt ≈-22.5 | ≈-22.5 | 27.9 | Unterbewertet | |
| P/S (TTM) | 7.55-Jahres-Durchschnitt ≈3.7 | ≈3.7 | 11.9 | Unterbewertet | |
| K/B (MRQ) | 8.15-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 4.2 | Unterbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | 81.95-Jahres-Durchschnitt ≈-25.8 | ≈-25.8 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 8.55-Jahres-Durchschnitt ≈3.9 | ≈3.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CDNA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 23.6%5-Jahres-Durchschnitt ≈-20.5% | ≈-20.5% | 12.5% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 26.8%5-Jahres-Durchschnitt ≈-17.8% | ≈-17.8% | 12.5% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 25.1%5-Jahres-Durchschnitt ≈-18.4% | ≈-18.4% | 16.4% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 24.2%5-Jahres-Durchschnitt ≈-18.4% | ≈-18.4% | 10.2% | Spitzenklasse | |
| ROA (TTM) | 22.7%5-Jahres-Durchschnitt ≈-10.4% | ≈-10.4% | -13.8% | Spitzenklasse | |
| ROE (TTM) | 29.5%5-Jahres-Durchschnitt ≈-14.5% | ≈-14.5% | -10.7% | Spitzenklasse | |
| ROIC | -10.3%5-Jahres-Durchschnitt ≈-20.3% | ≈-20.3% | -12.3% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CDNA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 4.65-Jahres-Durchschnitt ≈4.3 | ≈4.3 | 4.6 | Im Einklang | |
| Quick Ratio (MRQ) | 4.45-Jahres-Durchschnitt ≈4.0 | ≈4.0 | 4.1 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CDNA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 13.8%5-Jahres-Durchschnitt ≈16.6% | ≈16.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 5.7%5-Jahres-Durchschnitt ≈7.7% | ≈7.7% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 14.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CDNA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.4 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 7.15-Jahres-Durchschnitt ≈5.8 | ≈5.8 | 8.4 | Unterdurchschnittlich | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$499.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
44.4%
Nächster Bericht
Nov 02, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 4, 2026 | $0.37 | $0.24 | 55.8% |
| 31. März 2026 | $0.34 | $0.14 | 149.6% | |
| 31. Dezember 2025 | $0.12 | $0.24 | -50.8% | |
| 30. September 2025 | $0.28 | $0.14 | 93.8% | |
| 30. Juni 2025 | $0.10 | $0.12 | -18.1% | |
| 31. März 2025 | $0.09 | $0.07 | 36.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $380M | $334M | $280M | $322M | $296M | $192M | $127M | $77M | $48M | $41M | $28M | $27M | |
| Cost of Revenue | · | · | · | · | · | · | $45M | $33M | $21M | $10M | $0 | $0 | |
| Gross Profit | · | · | · | · | · | · | $82M | $44M | $27M | · | · | · | |
| R&D Expense | $71M | $73M | $82M | $90M | $77M | $49M | $31M | $15M | $12M | $12M | $9M | $4M | |
| SG&A Expense | $108M | $125M | $119M | $100M | $75M | $49M | $37M | $23M | $20M | $21M | $12M | $8M | |
| Operating Expenses | $411M | $293M | $484M | $399M | $326M | $215M | $152M | $92M | $47M | $78M | $40M | $26M | |
| Operating Income | $-31M | $41M | $-203M | $-77M | $-30M | $-23M | $-25M | $-16M | $-20M | $-37M | $-12M | $1M | |
| Other Non-op | $524.0K | $329.0K | $1M | $-3M | $-3M | $-811.0K | $-719.0K | $-178.0K | $-1M | $-2M | $-188.0K | $-78.0K | |
| Pretax Income | $-21M | $53M | $-190M | $-76M | $-32M | $-20M | $-24M | $-48M | $-57M | $-41M | $-14M | $-719.0K | |
| Income Tax | $271.0K | $310.0K | $141.0K | $379.0K | $-1M | $-1M | $-2M | $-1M | $-2M | $-2M | $0 | $-2M | |
| Net Income | $-21M | $53M | $-190M | $-77M | $-31M | $-19M | $-22M | $-47M | $-55M | $-39M | $-14M | $781.0K | |
| EPS (Basic) | $-0.40 | $1.00 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.13 | |
| EPS (Diluted) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.10 | |
| Shares (Basic) | 53,287,546 | 52,773,247 | 53,764,705 | 53,321,625 | 52,241,076 | 46,481,772 | 42,151,617 | 35,638,956 | 23,332,503 | 16,496,911 | 11,860,885 | 5,815,928 | |
| Shares (Diluted) | 53,287,546 | 56,620,590 | 53,764,705 | 53,321,625 | 52,241,076 | 46,481,772 | 42,151,617 | 35,638,956 | 23,332,503 | 16,496,911 | 11,860,885 | 9,283,001 | |
| EBITDA | $-16M | $55M | $-189M | $-77M | $-30M | $-23M | $-25M | $-16M | $-20M | · | · | $2M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $115M | $82M | $90M | $348M | $135M | $38M | $65M | $17M | $17M | $30M | $36M | |
| Short-term Investments | $112M | $146M | $153M | $203M | $0 | $90M | $0 | · | · | · | · | · | |
| Receivables | $43M | $65M | $51M | $66M | $60M | $35M | $24M | $10M | $3M | $3M | · | · | |
| Inventory | $27M | $20M | $19M | $19M | $17M | $10M | $6M | $5M | $6M | $5M | $766.0K | $686.0K | |
| Prepaid Expense | $11M | $7M | $8M | $9M | $8M | $4M | $4M | $2M | $1M | $1M | $1M | $542.0K | |
| Current Assets | $257M | $352M | $314M | $388M | $433M | $273M | $72M | $81M | $27M | $27M | $34M | $40M | |
| PP&E (Net) | $33M | $34M | $35M | $36M | $22M | $11M | $4M | $4M | $2M | $3M | $2M | $2M | |
| PP&E (Gross) | · | · | · | · | · | · | · | $18M | $18M | $17M | $14M | $13M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $14M | $15M | $14M | $12M | $11M | |
| Goodwill | $40M | $40M | $40M | $38M | $37M | $24M | $24M | $12M | $12M | $14M | $12M | $12M | |
| Intangibles | $32M | $38M | $46M | $43M | $50M | $44M | $46M | $33M | $33M | $33M | $7M | $7M | |
| Other Non-current Assets | $3M | $2M | $1M | $4M | $6M | $1M | $1M | $0 | $0 | $20.0K | $49.0K | $25.0K | |
| Total Assets | $413M | $491M | $467M | $543M | $567M | $369M | $152M | $131M | $84M | $77M | $56M | $61M | |
| Accounts Payable | $10M | $8M | $13M | $10M | $13M | $10M | $6M | $5M | $3M | $3M | $2M | $1M | |
| Current Liabilities | $90M | $89M | $78M | $76M | $77M | $69M | $35M | $20M | $43M | $41M | $10M | $11M | |
| Capital Leases | $20M | $22M | $28M | $33M | $17M | $16M | $2M | $249.0K | $14.0K | $26.0K | $57.0K | $106.0K | |
| Deferred Tax | $181.0K | $164.0K | $136.0K | $0 | $415.0K | $1M | $2M | $3M | $5M | $6M | $0 | · | |
| Other Non-current Liabilities | $418.0K | $645.0K | $97M | $249.0K | $455.0K | $240.0K | $2M | $2M | $1M | $1M | $28.0K | $28.0K | |
| Total Liabilities | $110M | $113M | $205M | $112M | $101M | $91M | $53M | $35M | $90M | $57M | $26M | $20M | |
| Long-term Debt | · | · | · | · | · | $0 | $0 | $0 | $34M | $24M | $16M | $11M | |
| Total Debt | · | · | · | · | · | $0 | $0 | $0 | $34M | · | · | $11M | |
| Common Stock | $50.0K | $51.0K | $49.0K | $52.0K | $52.0K | $49.0K | $42.0K | $41.0K | $29.0K | $21.0K | $12.0K | $12.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $236M | $203M | $201M | |
| Retained Earnings | $-619M | $-626M | $-678M | $-460M | $-383M | $-353M | $-334M | $-312M | $-268M | $-213M | $-173M | $-159M | |
| AOCI | $-6M | $-9M | $-7M | $-8M | $-5M | $-2M | $-5M | $-4M | $-2M | $-4M | $0 | · | |
| Stockholders' Equity | $303M | $378M | $261M | $431M | $466M | $278M | $99M | $96M | $-6M | $19M | $29M | $41M | |
| Liabilities + Equity | $413M | $491M | $467M | $543M | $567M | $369M | $152M | $131M | $84M | $77M | $56M | $61M | |
| Shares Outstanding | 50,916,644 | 54,771,203 | 51,503,377 | 53,533,250 | 52,923,360 | 49,441,166 | 42,498,430 | 41,384,960 | 28,825,019 | 21,278,373 | 11,902,363 | 11,803,970 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $14M | $14M | $12M | $9M | $7M | $6M | $4M | $4M | $3M | $796.0K | $512.0K | |
| Stock-based Comp | $35M | $66M | $49M | $47M | $36M | $23M | $22M | $7M | $2M | $2M | $1M | $535.0K | |
| Deferred Tax | $-149.0K | $101.0K | $72.0K | $-278.0K | $-1M | $-1M | $-1M | $-2M | $-2M | $-2M | $0 | $-2M | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $4M | $2M | $3M | $2M | $0 | · | |
| Restructuring | · | $2M | $2M | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $14M | $-95M | $108M | · | · | · | · | · | · | · | · | $-5M | |
| Operating Cash Flow | $42M | $38M | $-18M | $-25M | $-19M | $33M | $-3M | $-4M | $-14M | $-17M | $-10M | $-3M | |
| CapEx | · | · | · | · | · | · | · | $2M | $186.0K | $549.0K | $1M | $733.0K | |
| Investing Cash Flow | $2M | $-483.0K | $40M | $-229M | $48M | $-100M | $-23M | $-8M | $-6M | $-21M | · | · | |
| Stock Issued | · | · | $0 | $0 | $189M | · | · | · | · | · | · | · | |
| Stock Repurchased | $88M | $522.0K | $28M | $642.0K | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $-88M | $-522.0K | $-28M | $-642.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-93M | $-6M | $-30M | $-5M | $186M | $163M | $-132.0K | $50M | $29M | $25M | · | · | |
| Net Change in Cash | $-49M | $32M | $-8M | $-258M | $214M | $96M | $-26M | $38M | $9M | $-13M | $-7M | $31M | |
| Taxes Paid | $284.0K | $317.0K | $738.0K | $392.0K | $14.0K | $80.0K | $0 | $0 | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | $-6M | $-14M | · | · | $-4M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 64.2% | · | · | · | · | · | |
| Operating Margin | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% | · | · | 4.6% | |
| Net Margin | -5.6% | 15.7% | -67.9% | -23.8% | -10.3% | -9.7% | -17.3% | -61.1% | -114.8% | · | · | 2.9% | |
| Pretax Margin | -5.5% | 15.8% | -67.8% | -23.7% | -10.8% | -10.3% | -18.9% | -63.0% | -118.5% | · | · | -2.6% | |
| EBITDA Margin | -4.2% | 16.5% | -67.4% | -24.0% | -10.0% | -11.7% | -19.3% | -20.3% | -42.0% | · | · | 6.5% | |
| ROA | -4.7% | 11.0% | -37.7% | -13.8% | -6.6% | -7.2% | -15.6% | -43.6% | -69.9% | · | · | 2.2% | |
| ROE | -6.8% | 16.1% | -58.1% | -17.1% | -6.5% | -6.9% | -22.4% | -104.1% | -831.1% | · | · | -1.4% | |
| ROIC | -10.3% | 10.7% | -77.9% | -18.0% | -6.1% | -7.7% | -22.7% | -15.8% | -70.5% | · | · | -2.6% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 3.9 | 4.0 | 5.1 | 5.6 | 3.9 | 2.1 | 4.2 | 0.6 | · | · | 3.6 | |
| Quick Ratio | 2.4 | 3.6 | 3.7 | 4.7 | 5.3 | 3.7 | 1.8 | 3.8 | 0.5 | · | · | 3.3 | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | -5.6 | · | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | 0.0 | -3.0 | · | · | 0.1 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.9 | 0.7 | 0.6 | · | · | 0.8 | |
| Inventory Turnover | · | · | · | · | · | · | 8.3 | · | 1.6 | · | · | 14.2 | |
| Receivables Turnover | 7.1 | 5.8 | 4.8 | 5.1 | 6.3 | 6.6 | 7.5 | 12.0 | 16.8 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.95 | $6.91 | $5.07 | $8.05 | $8.80 | $5.62 | $2.33 | $2.32 | $-0.21 | · | · | $3.50 | |
| Revenue / Share | $7.13 | $5.90 | $5.21 | $6.03 | $5.67 | $4.13 | $3.01 | $2.15 | $2.07 | · | · | $2.94 | |
| Cash Flow / Share | $0.79 | $0.67 | $-0.34 | $-0.47 | $-0.37 | $0.72 | $-0.07 | $-0.11 | $-0.61 | · | · | $-0.36 | |
| Cash / Share | $1.28 | $2.09 | $1.60 | $1.68 | $6.58 | $2.72 | $0.90 | $1.56 | $0.59 | · | · | $3.09 | |
| EPS (TTM) | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 | $-0.40 | $-0.52 | $-1.31 | $-2.38 | $-2.39 | $-1.16 | $0.10 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.8% | 19.1% | -12.9% | 8.6% | 54.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.7% | 4.0% | 13.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.6% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $380M | $334M | $280M | $322M | $296M | $192M | $127M | $77M | $48M | $41M | $28M | $27M | |
| Net Income TTM | $-21M | $53M | $-190M | $-77M | $-31M | $-19M | $-22M | $-47M | $-55M | $-39M | $-14M | $781.0K | |
| Market Cap | $959M | $1.17B | $618M | $611M | $2.41B | $3.58B | $917M | $1.04B | $212M | · | · | $86M | |
| Enterprise Value | · | · | · | · | · | $3.36B | $878M | $976M | $229M | · | · | $61M | |
| P/E | -47.1 | 23.0 | -3.4 | -7.9 | -77.1 | -181.1 | -41.5 | -19.2 | -3.1 | -1.1 | -5.5 | 72.5 | |
| P/S | 2.5 | 3.5 | 2.2 | 1.9 | 8.1 | 18.6 | 7.2 | 13.6 | 4.4 | · | · | 3.1 | |
| P/B | 3.2 | 3.1 | 2.4 | 1.4 | 5.2 | 12.9 | 9.3 | 10.8 | -34.5 | · | · | 2.1 | |
| P / Tangible Book | 4.2 | 3.9 | 3.5 | 1.7 | 6.4 | 17.1 | · | · | · | · | · | · | |
| P / Cash Flow | 22.8 | 30.8 | -33.6 | -24.2 | -124.8 | 107.1 | -331.1 | -259.7 | -14.8 | · | · | -25.5 | |
| P / FCF | · | · | · | · | · | · | · | -172.2 | -14.6 | · | · | -21.0 | |
| EV / EBITDA | · | · | · | · | · | -149.0 | -35.8 | -62.6 | -11.3 | · | · | 34.4 | |
| EV / FCF | · | · | · | · | · | · | · | -161.5 | -15.8 | · | · | -14.8 | |
| EV / Revenue | · | · | · | · | · | 17.5 | 6.9 | 12.7 | 4.7 | · | · | 2.2 | |
| Earnings Yield | -2.1% | 4.3% | -29.5% | -12.6% | -1.3% | -0.55% | -2.4% | -5.2% | -32.4% | -88.5% | -18.1% | 1.4% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $132M | $118M | $108M | $100M | $87M | $85M | $87M | $83M | $92M | $72M | $66M | $67M | $70M | $77M | $82M | $79M | |
| R&D Expense | $22M | $21M | $19M | $17M | $17M | $19M | $17M | $17M | $20M | $19M | $19M | $19M | $20M | $24M | $24M | $22M | |
| SG&A Expense | $41M | $30M | $29M | $28M | $28M | $23M | $32M | $32M | $31M | $30M | $28M | $34M | $29M | $28M | $25M | $24M | |
| Operating Expenses | $19M | $117M | $114M | $100M | $98M | $98M | $2M | $97M | $100M | $95M | $188M | $96M | $98M | $102M | $102M | $97M | |
| Operating Income | $113M | $1M | $-6M | $-246.0K | $-11M | $-13M | $84M | $-14M | $-7M | $-23M | $-123M | $-29M | $-28M | $-24M | $-19M | $-17M | |
| Other Non-op | $-440.0K | $-330.0K | $264.0K | $-107.0K | $72.0K | $295.0K | $436.0K | $283.0K | $-100.0K | $-290.0K | $2M | $2M | $-271.0K | $-2M | $-924.0K | $-572.0K | |
| Pretax Income | $115M | $3M | $-4M | $2M | $-9M | $-10M | $88M | $-10M | $-5M | $-20M | $-118M | $-24M | $-25M | $-24M | $-18M | $-17M | |
| Income Tax | $4M | $-32.0K | $345.0K | $-15.0K | $-117.0K | $58.0K | $171.0K | $200.0K | $22.0K | $-83.0K | $165.0K | $-80.0K | $-68.0K | $124.0K | $173.0K | $267.0K | |
| Net Income | $111M | $3M | $-4M | $2M | $-9M | $-10M | $88M | $-11M | $-5M | $-20M | $-118M | $-23M | $-25M | $-24M | $-18M | $-17M | |
| EPS (Basic) | $2.15 | $0.05 | $-0.08 | $0.03 | $-0.16 | $-0.19 | $1.67 | $-0.20 | $-0.09 | $-0.38 | $-2.21 | $-0.43 | $-0.46 | $-0.44 | $-0.34 | $-0.32 | |
| EPS (Diluted) | $2.07 | $0.05 | $-0.08 | $0.03 | $-0.16 | $-0.19 | $1.60 | $-0.20 | $-0.09 | $-0.38 | $-2.21 | $-0.43 | $-0.46 | $-0.44 | $-0.34 | $-0.32 | |
| Shares (Basic) | 51,469,375 | 51,151,794 | · | 52,507,582 | 54,304,754 | 55,262,459 | · | 52,903,338 | 52,195,620 | 51,692,358 | · | 54,178,759 | 53,846,260 | 53,643,216 | · | 53,489,418 | |
| Shares (Diluted) | 53,422,523 | 53,129,928 | · | 53,736,790 | 54,304,754 | 55,262,459 | · | 52,903,338 | 52,195,620 | 51,692,358 | · | 54,178,759 | 53,846,260 | 53,643,216 | · | 53,489,418 | |
| EBITDA | $113M | $5M | · | $-246.0K | $-11M | $-10M | · | $-10M | $-4M | $-16M | · | $-29M | $-28M | $-21M | · | $-17M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $374M | $78M | $65M | $91M | $68M | $89M | $115M | $95M | $96M | $93M | $82M | $76M | $88M | $75M | $90M | $83M | |
| Short-term Investments | $0 | $109M | $112M | $103M | $118M | $142M | $146M | $145M | $133M | $123M | · | $192M | $195M | $211M | · | $208M | |
| Receivables | $34M | $45M | $43M | $48M | $67M | $71M | $65M | $67M | $66M | $60M | · | $52M | $52M | $59M | · | $70M | |
| Inventory | $7M | $26M | $27M | $28M | $28M | $23M | $20M | $19M | $19M | $20M | · | $18M | $19M | $18M | · | $18M | |
| Prepaid Expense | $14M | $11M | $11M | $30M | $26M | $25M | $7M | $7M | $6M | $7M | · | $7M | $8M | $8M | · | $8M | |
| Current Assets | $429M | $269M | $257M | $300M | $307M | $350M | $352M | $334M | $321M | $303M | · | $345M | $361M | $371M | · | $388M | |
| PP&E (Net) | $27M | $33M | $33M | $31M | $32M | $33M | $34M | $34M | $34M | $34M | · | $35M | $36M | $36M | · | $34M | |
| Goodwill | $36M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | $40M | · | $40M | $40M | $40M | $38M | $38M | |
| Intangibles | $19M | $32M | $32M | $33M | $36M | $37M | $38M | $40M | $42M | $43M | · | $46M | $44M | $46M | · | $44M | |
| Other Non-current Assets | $6M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $5M | |
| Total Assets | $533M | $411M | $413M | $432M | $444M | $490M | $491M | $477M | $467M | $452M | · | $501M | $515M | $528M | · | $545M | |
| Accounts Payable | $9M | $9M | $10M | $12M | $10M | $8M | $8M | $6M | $6M | $10M | · | $9M | $10M | $13M | · | $11M | |
| Current Liabilities | $94M | $79M | $90M | $99M | $93M | $85M | $89M | $81M | $78M | $70M | · | $73M | $74M | $72M | · | $70M | |
| Capital Leases | $13M | $18M | $20M | $21M | $23M | $24M | $22M | $24M | $25M | $27M | · | $29M | $31M | $32M | · | $35M | |
| Deferred Tax | $86.0K | $130.0K | $181.0K | $117.0K | $131.0K | $129.0K | $164.0K | $202.0K | $50.0K | $43.0K | · | $140.0K | $51.0K | · | · | $13.0K | |
| Other Non-current Liabilities | $406.0K | $407.0K | $257.0K | $634.0K | $636.0K | $644.0K | $645.0K | $97M | $97M | $98M | · | $245.0K | $247.0K | $248.0K | · | $251.0K | |
| Total Liabilities | $107M | $98M | $110M | $121M | $117M | $110M | $113M | $204M | $202M | $196M | · | $107M | $110M | $108M | · | $108M | |
| Long-term Debt | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Common Stock | $51.0K | $51.0K | $50.0K | $51.0K | $53.0K | $51.0K | $51.0K | $50.0K | $50.0K | $49.0K | · | $52.0K | $52.0K | $52.0K | · | $52.0K | |
| Retained Earnings | $-505M | $-733M | $-735M | $-719M | $-695M | $-637M | $-626M | $-704M | $-697M | $-695M | · | $-534M | $-510M | $-485M | · | $-441M | |
| AOCI | $0 | $-6M | $-6M | $-6M | $-6M | $-7M | $-9M | $-7M | $-8M | $-8M | · | $-9M | $-8M | $-7M | · | $-9M | |
| Stockholders' Equity | $426M | $314M | $303M | $311M | $327M | $379M | $378M | $273M | $265M | $256M | $261M | $394M | $405M | $420M | $431M | $437M | |
| Liabilities + Equity | $533M | $411M | $413M | $432M | $444M | $490M | $491M | $477M | $467M | $452M | · | $501M | $515M | $528M | · | $545M | |
| Shares Outstanding | 51,482,536 | 51,274,651 | 50,916,644 | 51,407,335 | 53,220,123 | 55,462,730 | 54,771,203 | 53,106,871 | 52,617,443 | 51,782,612 | 51,503,377 | 54,153,496 | 54,013,601 | 53,653,182 | 53,533,250 | 53,523,453 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Stock-based Comp | $11M | $10M | $8M | $8M | $9M | $9M | $17M | $23M | $20M | $17M | $10M | $13M | $13M | $14M | $12M | $11M | |
| Amort. of Intangibles | $529.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | $0 | $68.0K | · | · | $0 | $848.0K | $60.0K | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-29M | · | · | · | $-16M | · | · | · | $7M | · | · | |
| Operating Cash Flow | $31M | $4M | $21M | $37M | $10M | $-27M | $22M | $13M | $19M | $-15M | $-8M | $-10M | $-499.0K | $671.0K | $7M | $-7M | |
| CapEx | $2M | $4M | · | · | $1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $281M | $11M | $-35M | $12M | $23M | $1M | $-2M | $-14M | $-12M | $28M | $41M | $-1M | $15M | $-15M | $2M | $-76M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | · | · | $12M | $26M | $50M | $0 | $0 | $0 | $0 | $522.0K | $26M | $814.0K | $67.0K | $690.0K | $642.0K | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-522.0K | · | · | · | $-690.0K | · | · | |
| Financing Cash Flow | $-15M | $-3M | $-12M | $-26M | $-54M | $-643.0K | $-903.0K | $1M | $-5M | $-1M | $-27M | $-25.0K | $-2M | $-1M | $-2M | $-1M | |
| Net Change in Cash | $296M | $12M | $-26M | $23M | $-21M | $-26M | $19M | $-378.0K | $2M | $11M | $6M | $-12M | $13M | $-15M | $7M | $-84M | |
| Free Cash Flow | · | $514.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 85.8% | 1.0% | · | -0.25% | -12.8% | -15.8% | · | -12.7% | -4.4% | -26.8% | · | -42.8% | -39.3% | -31.5% | · | -21.9% | |
| Net Margin | 83.9% | 2.4% | · | 1.7% | -9.9% | -12.2% | · | -8.9% | -1.5% | -23.1% | · | -34.9% | -35.5% | -30.7% | · | -21.3% | |
| Pretax Margin | 86.8% | 2.4% | · | 1.7% | -10.0% | -12.2% | · | -8.7% | -1.5% | -23.2% | · | -35.1% | -35.6% | -30.6% | · | -21.0% | |
| EBITDA Margin | 85.8% | 4.3% | · | -0.25% | -12.8% | -11.5% | · | -12.7% | -4.4% | -21.5% | · | -42.8% | -39.3% | -27.1% | · | -21.9% | |
| ROA | 22.6% | 0.62% | · | 0.37% | -1.9% | -2.2% | · | -1.5% | -0.28% | -3.4% | · | -4.5% | -4.7% | -4.4% | · | -3.1% | |
| ROE | 29.4% | 0.81% | · | 0.57% | -2.9% | -3.3% | · | -2.2% | -0.42% | -4.9% | · | -5.7% | -5.9% | -5.4% | · | -3.7% | |
| ROIC | 25.7% | 0.39% | · | -0.08% | -3.4% | -3.5% | · | -4.0% | -1.6% | -7.5% | · | -7.3% | -6.8% | -5.8% | · | -4.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.4 | · | 3.0 | 3.3 | 4.1 | · | 4.1 | 4.1 | 4.3 | · | 4.7 | 4.8 | 5.2 | · | 5.5 | |
| Quick Ratio | 4.4 | 2.9 | · | 2.4 | 2.7 | 3.5 | · | 3.8 | 3.8 | 3.9 | · | 4.4 | 4.5 | 4.8 | · | 5.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 2.6 | 2.0 | · | 1.7 | 1.3 | 1.3 | · | 1.4 | 1.6 | 1.2 | · | 1.1 | 1.2 | 1.2 | · | 1.3 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.27 | $6.11 | · | $6.05 | $6.15 | $6.84 | · | $5.15 | $5.03 | $4.95 | · | $7.28 | $7.50 | $7.83 | · | $8.16 | |
| Revenue / Share | $2.47 | $2.22 | · | $1.86 | $1.60 | $1.53 | · | $1.57 | $1.77 | $1.39 | · | $1.24 | $1.31 | $1.44 | · | $1.48 | |
| Cash Flow / Share | · | $0.08 | · | · | · | $-0.48 | · | · | · | $-0.30 | · | · | · | $0.01 | · | · | |
| Cash / Share | $7.26 | $1.52 | · | $1.78 | $1.28 | $1.60 | · | $1.80 | $1.82 | $1.80 | · | $1.40 | $1.63 | $1.39 | · | $1.55 | |
| EPS (TTM) | $2.07 | $-0.16 | · | $1.28 | $1.05 | $1.12 | · | $-2.88 | $-3.11 | $-3.48 | · | $-1.67 | $-1.56 | $-1.51 | · | $-1.41 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $458M | $413M | · | $358M | $341M | $346M | · | $313M | $297M | $275M | · | $297M | $309M | $320M | · | $319M | |
| Net Income TTM | $111M | $-8M | · | $70M | $58M | $62M | · | $-153M | $-166M | $-186M | · | $-91M | $-84M | $-81M | · | $-74M | |
| Market Cap | $1.47B | $890M | · | $747M | $1.04B | $984M | · | $1.66B | $817M | $548M | · | $379M | $459M | $490M | · | $911M | |
| P/E | 13.8 | -108.5 | · | 11.4 | 18.6 | 15.8 | · | -10.8 | -5.0 | -3.0 | · | -4.2 | -5.4 | -6.1 | · | -12.1 | |
| P/S | 3.2 | 2.2 | · | 2.1 | 3.1 | 2.8 | · | 5.3 | 2.8 | 2.0 | · | 1.3 | 1.5 | 1.5 | · | 2.9 | |
| P/B | 3.4 | 2.8 | · | 2.4 | 3.2 | 2.6 | · | 6.1 | 3.1 | 2.1 | · | 1.0 | 1.1 | 1.2 | · | 2.1 | |
| P / Tangible Book | 4.0 | 3.7 | · | 3.1 | 4.1 | 3.3 | · | 8.6 | 4.5 | 3.2 | · | 1.2 | 1.4 | 1.5 | · | 2.6 | |
| P / Cash Flow | · | 205.4 | · | · | · | -37.0 | · | · | · | -35.8 | · | · | · | 730.8 | · | · | |
| Earnings Yield | 7.3% | -0.92% | · | 8.8% | 5.4% | 6.3% | · | -9.2% | -20.0% | -32.9% | · | -23.9% | -18.4% | -16.5% | · | -8.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $380M | $334M | $280M | $322M | $296M |
| Betriebsgewinnmarge % | -8.1% | 12.2% | -72.5% | -24.0% | -10.0% |
| Nettoergebnis | $-21M | $53M | $-190M | $-77M | $-31M |
| Verwässerte EPS | $-0.40 | $0.93 | $-3.54 | $-1.44 | $-0.59 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.9 | 3.9 | 4.0 | 5.1 | 5.6 |
| Quick Ratio | 2.4 | 3.6 | 3.7 | 4.7 | 5.3 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 241 Einreicher · $1.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
241
Gehaltener Wert
$1.6B
Neue Positionen
54
Geschlossene Positionen
13
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 54 (+25 vs. Vorquartal) | 13 (-16 vs. Vorquartal) | 77 (+6 vs. Vorquartal) | 66 (+8 vs. Vorquartal) | +368K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $137.219.211 | 4.814.709 | 8,74% | Aktien |
| STATE STREET CORP | $70.362.453 | 2.468.858 | 4,48% | Aktien |
| VANGUARD GROUP INC | $64.588.269 | 3.428.252 | 4,11% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $62.628.038 | 2.197.475 | 3,99% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $56.932.113 | 1.997.618 | 3,63% | Aktien |
| ARK Investment Management LLC | $55.675.622 | 1.953.531 | 3,55% | Aktien |
| Boston Partners | $55.224.627 | 1.937.601 | 3,52% | Aktien |
| BAMCO INC /NY/ | $55.213.791 | 1.937.326 | 3,52% | Aktien |
| GAGNON SECURITIES LLC | $50.465.960 | 1.770.735 | 3,21% | Aktien |
| Chevy Chase Trust Holdings, LLC | $40.966.358 | 1.437.416 | 2,61% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $37.856.083 | 1.328.037 | 2,41% | Aktien |
| Ophir Asset Management Pty Ltd | $36.047.057 | 1.264.809 | 2,30% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $35.424.332 | 1.242.959 | 2,26% | Aktien |
| BRAIDWELL LP | $34.787.157 | 1.220.602 | 2,22% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $33.961.455 | 1.191.630 | 2,16% | Aktien |
| Blue Water Life Science Advisors, LP | $33.915.000 | 1.190.000 | 2,16% | Aktien |
| Amova Asset Management Americas, Inc. | $33.848.257 | 1.188.075 | 2,16% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $33.664.351 | 1.181.077 | 2,14% | Aktien |
| D. E. Shaw & Co., Inc. | $32.423.311 | 1.137.660 | 2,07% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $28.376.566 | 995.669 | 1,81% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $28.201.577 | 989.529 | 1,80% | Aktien |
| MORGAN STANLEY | $22.067.528 | 774.299 | 1,41% | Aktien |
| Divisadero Street Capital Management, LP | $19.976.733 | 700.938 | 1,27% | Aktien |
| GOLDMAN SACHS GROUP INC | $19.949.801 | 699.993 | 1,27% | Aktien |
| Portolan Capital Management, LLC | $19.516.943 | 684.805 | 1,24% | Aktien |
| First Eagle Investment Management, LLC | $17.057.165 | 598.497 | 1,09% | Aktien |
| ROYCE & ASSOCIATES LP | $16.415.174 | 575.971 | 1,05% | Aktien |
| BANK OF AMERICA CORP /DE/ | $16.296.528 | 571.808 | 1,04% | Aktien |
| Gagnon Advisors, LLC | $15.586.451 | 546.893 | 0,99% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $15.336.563 | 538.125 | 0,98% | Aktien |
| Palo Alto Investors LP | $15.158.295 | 531.870 | 0,97% | Aktien |
| Russell Investments Group, Ltd. | $14.636.172 | 513.550 | 0,93% | Aktien |
| NORTHERN TRUST CORP | $13.645.745 | 478.798 | 0,87% | Aktien |
| JANE STREET GROUP, LLC | $13.402.781 | 470.273 | 0,85% | Aktien |
| Meridiem Capital Partners LP | $12.867.551 | 451.493 | 0,82% | Aktien |
| Invesco Ltd. | $12.745.344 | 447.205 | 0,81% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $11.456.630 | 401.987 | 0,73% | Aktien |
| Zweig-DiMenna Associates LLC | $11.081.142 | 388.812 | 0,71% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $10.684.906 | 374.909 | 0,68% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.605.164 | 372.111 | 0,68% | Aktien |
| Qube Research & Technologies Ltd | $10.540.355 | 369.837 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $10.446.419 | 366.541 | 0,67% | Aktien |
| ArrowMark Colorado Holdings LLC | $9.648.647 | 338.549 | 0,61% | Aktien |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | $8.680.000 | 500.000 | 0,55% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $8.441.700 | 296.200 | 0,54% | Aktien |
| Kent Lake PR LLC | $7.997.000 | 550.000 | 0,51% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $7.643.900 | 268.207 | 0,49% | Aktien |
| FMR LLC | $7.219.454 | 253.314 | 0,46% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $6.964.688 | 244.375 | 0,44% | Aktien |
| Aberdeen Group plc | $6.407.627 | 224.829 | 0,41% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Merckle International GmbH ×3 Einreichungen | 28. März 2018 | · | Erste Einreichung | Passive Anlage | SEC |
| Paragon Associates and Paragon Associates II Joint Venture, Paragon JV Partners, LLC, Bradbury Dyer III ×4 Einreichungen | 24. Januar 2018 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 37 Insider · 21 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John Walter Hanna JR | President and CEO | 16. Juli 2026 M | 653.448 | 0 | 11 | $-7.540.215 |
| Reginald Seeto | President and Chief Executive Officer | 2. Oktober 2023 S | 479.164 | 0 | 0 | $0 |
| Keith Kennedy | CFO & COO | 12. September 2026 F | 211.704 | 0 | 0 | $0 |
| Nathan Smith | Chief Financial Officer | 2. Februar 2026 F | 79.016 | 0 | 0 | $0 |
| Abhishek Jain | Chief Financial Officer | 1. August 2025 F | 319.725 | 0 | 0 | $0 |
| Ankur Dhingra | Chief Financial Officer | 25. März 2022 F | 33.146 | 0 | 0 | $0 |
| Michael Brian Bell | Chief Financial Officer | 3. November 2020 M | 103.343 | 0 | 0 | $0 |
| Charles Constanti | Chief Financial Officer | 17. Februar 2017 A | 10.000 | 0 | 0 | $0 |
| Ken Ludlum | Chief Financial Officer | 22. Januar 2016 A | 48.000 | 0 | 0 | $0 |
| Alexander L Johnson | President of Patient and Testing Services | 21. August 2024 M | 284.983 | 0 | 0 | $0 |
| Mitchell J Nelles | Chief Operating Officer | 2. Juli 2018 S | 85.160 | 0 | 0 | $0 |
| Jessica Meng | Chief Commercial Officer | 12. September 2026 F | 161.599 | 0 | 0 | $0 |
| Jeffrey Adam Novack | Secretary and General Counsel | 5. August 2026 S | 106.075 | 0 | 7 | $-452.796 |
| Abraham Ronai | Führungskraft | 20. September 2023 A | 515.986 | 0 | 0 | $0 |
| Sasha King | Chief Marketing Officer | 9. August 2022 A | 78.420 | 0 | 0 | $0 |
| James P Yee | Chief Medical Officer | 1. Juli 2019 M | 42.045 | 0 | 0 | $0 |
| John Joseph Sninsky | Chief Scientific Officer | 29. Januar 2018 F | 22.309 | 0 | 0 | $0 |
| Anders Karlsson | Chief Commercial Officer | 19. Januar 2018 A | 9.638 | 0 | 0 | $0 |
| Todd Whitson | Chief Commercial Officer | 17. Februar 2017 A | 20.000 | 0 | 0 | $0 |
| Joshua Defonzo | Chief Commercial Officer | 22. Januar 2016 A | 11.000 | 0 | 0 | $0 |
| Matthew J. Meyer | Chief Business Officer | 22. Januar 2016 A | 23.025 | 0 | 0 | $0 |
| Hannah Valantine | Direktor | 16. Juli 2026 M | 36.686 | 0 | 3 | $-1.319.814 |
| Suresh Gunasekaran | Direktor | 12. Juni 2026 A | 37.248 | 0 | 0 | $0 |
| Richard Bryan Riggsbee | Direktor | 12. Juni 2026 A | 39.312 | 0 | 0 | $0 |
| Fred Cohen | Direktor | 12. Juni 2026 A | 165.060 | 0 | 0 | $0 |
| Peter Maag | Direktor | 7. Juli 2025 S | 308.846 | 0 | 0 | $0 |
| William A Hagstrom | Direktor | 11. Juni 2025 M | 53.979 | 0 | 0 | $0 |
| Grace Colon | Direktor | 16. Juni 2023 A | 23.708 | 0 | 0 | $0 |
| Ralph Snyderman | Direktor | 4. Oktober 2022 A | 58.177 | 0 | 0 | $0 |
| Amy Abernethy | Direktor | 22. Januar 2019 M | 15.837 | 0 | 0 | $0 |
| Douglas S Miller | Direktor | 1. April 2017 A | 17.695 | 0 | 0 | $0 |
| Neil Gagnon | 10%-Eigentümer | 31. Oktober 2018 S | 867.744 | 0 | 0 | $0 |
| George Bickerstaff | · | 5. August 2026 S | 134.061 | 0 | 1 | $-925.600 |
| Michael Goldberg | · | 4. August 2026 S | 61.738 | 0 | 1 | $-2.103.582 |
| Christine Cournoyer | · | 4. August 2026 S | 42.943 | 0 | 1 | $-751.040 |
| Arthur A Torres | · | 15. Mai 2026 S | 38.665 | 0 | 2 | $-214.650 |
| BYERS BROOK H | · | 1. Juli 2016 A | 21.912 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 42 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 4,30% | 1.531.579 NS | 31. Juli 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,68% | 42.385 NS | 31. Juli 2026 | N-PORT |
| SAWS · ETF Series Solutions | 1,43% | 2.554 NS | 31. Juli 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 1,07% | 88.521 NS | 31. Juli 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,95% | 229.825 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,61% | 174.097 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,47% | 18.953 SH | 1. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,34% | 38.851 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,17% | 356.183 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,17% | 482.280 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,16% | 65.153 SH | 1. Oktober 2026 | Täglich |
| NUSC · Nushares ETF Trust | 0,14% | 42.483 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,12% | 69.521 SH | 11. September 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 30.344 SH | 1. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,10% | 531 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 54.986 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,08% | 1.317.079 SH | 11. September 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,08% | 19.899 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,07% | 24.512 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,05% | 172.629 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 295.088 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,04% | 7.437 SH | 11. September 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,03% | 4.860 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 20.688 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 2.782 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 591.907 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 131.033 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 136.968 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 4.263 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3.171 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 710 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.121 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 76.915 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 10.288 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 12.572 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 13.233 SH | 8. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 12.950 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.554.868 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.148 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 2.150 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 5.217 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 60.988 SH | 11. September 2026 | Täglich |
CDNA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$61.00
-9,2%
5 38,5%
Starker Kauf
4 30,8%
Kauf
4 30,8%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-02Mittelwert-Ziel $58.83 -12,4%
Jetzt
Aktueller Preis $67.15
Tief$46.00
Mittelwert$58.83
Hoch$74.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| PBLS | · | · | · | · | · | · |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 30, 2026